跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32 条关于
“BlueRock”
全部
32
临床试验
1
药物
4
机构
1
资讯
26
4年前
Bayer's BlueRock Therapeutics Expands to Europe with New Berlin Site
去年
BlueRock Therapeutics' Bemdaneprocel Advances to Phase 3 for Parkinson's Disease
去年
BlueRock Therapeutics Partners with Digital Health Companies to Advance Parkinson's Disease Clinical Trials
2年前
BlueRock Therapeutics' Bemdaneprocel Shows Promise in Parkinson's Disease Phase I Trial
去年
BlueRock Therapeutics Reports Promising 18-Month Data from Phase 1 Parkinson's Cell Therapy Trial in Nature Publication
去年
BlueRock Therapeutics Advances Bemdaneprocel to Phase III for Parkinson's Disease as Market Projected to Reach $7.0 Billion by 2033
2年前
BlueRock Therapeutics' OpCT-001 Receives FDA Clearance for Phase I/IIa Trial in Primary Photoreceptor Diseases
2年前
BlueRock Therapeutics' Bemdaneprocel Receives FDA RMAT Designation for Parkinson's Disease
去年
FDA Grants Fast Track Status to BlueRock's Novel Cell Therapy for Inherited Retinal Diseases
去年
BlueRock Therapeutics' Cell Therapy Shows Promise in Phase I Parkinson's Disease Trial
第 1 页,共 3 页
上一页
下一页